Skip to main content
Erschienen in: Acta Neurologica Belgica 1/2020

02.02.2019 | Neuro-Images

MRI findings in trigeminal neuropathy: bilateral Meckel’s cave lesions

verfasst von: Philipp Karschnia, Soma Sengupta, Jorg Dietrich

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

A 43-year-old woman presented during wintertime after a 2-day episode of acute facial pain in the ophthalmic (V1) division of the right trigeminal nerve, and numbness in both the right maxillary (V2) and mandibular (V3) divisions. Her history was remarkable for seronegative arthritis and bronchiolitis obliterans with organizing pneumonia (BOOP), though she was not on immunosuppressive therapy. Symptoms spontaneously resolved, and no focal findings were appreciated on neurological examination. CRP was 9.3 mg/L, ANA was positive at 1:160, and ACE level was within normal range. Magnetic resonance imaging (MRI) revealed an enhancing expansile mass within the right Meckel’s cave extending into the right foramen ovale (Fig. 1a, d). Computed tomography of the chest showed changes consistent with BOOP and new nodules measuring < 5 mm in size of undetermined etiology. Given that the patient was asymptomatic, she was monitored with surveillance MRI which was stable after 6 months. Repeat MRI of the brain a year after initial presentation showed resolution of the previously noted lesion within the right Meckel’s cave; however, an enhancing mass was surprisingly detected within the left Meckel’s cave (Fig. 1b, e). The patient denied to have symptoms at that time point and no treatment was administered. MRI of the brain 2 years after initial presentation demonstrated resolution of the left-sided enhancing mass with no evidence of residual lesions in both Meckel’s caves (Fig. 1c, f). Six years after initial presentation, she has remained clinically stable with no lesion recurrence. …
Literatur
1.
Zurück zum Zitat Gelfand JM (2017) Demystifying neurosarcoidosis and informing prognosis. JAMA Neurol 74:1296–1298CrossRef Gelfand JM (2017) Demystifying neurosarcoidosis and informing prognosis. JAMA Neurol 74:1296–1298CrossRef
2.
Zurück zum Zitat Janjua RM, Wong KM, Parekh A et al (2010) Management of the great mimicker: Meckel cave tumors. Neurosurgery 67:416–421PubMed Janjua RM, Wong KM, Parekh A et al (2010) Management of the great mimicker: Meckel cave tumors. Neurosurgery 67:416–421PubMed
3.
Zurück zum Zitat Joubert B, Chapelon-Abric C, Biard L et al (2017) Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis. JAMA Neurol 74:1336–1344CrossRef Joubert B, Chapelon-Abric C, Biard L et al (2017) Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis. JAMA Neurol 74:1336–1344CrossRef
4.
Zurück zum Zitat Malhotra A, Tu L, Kalra VB et al (2018) Neuroimaging of Meckel’s cave in normal and disease conditions. Insights Imaging 9:499–510CrossRef Malhotra A, Tu L, Kalra VB et al (2018) Neuroimaging of Meckel’s cave in normal and disease conditions. Insights Imaging 9:499–510CrossRef
5.
Zurück zum Zitat Valeyre D, Prasse A, Nunes H et al (2014) Sarcoidosis. Lancet 383:1155–1167CrossRef Valeyre D, Prasse A, Nunes H et al (2014) Sarcoidosis. Lancet 383:1155–1167CrossRef
Metadaten
Titel
MRI findings in trigeminal neuropathy: bilateral Meckel’s cave lesions
verfasst von
Philipp Karschnia
Soma Sengupta
Jorg Dietrich
Publikationsdatum
02.02.2019
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 1/2020
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-019-01091-w

Weitere Artikel der Ausgabe 1/2020

Acta Neurologica Belgica 1/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.